Massachusetts Financial Services Co. MA Has $327.84 Million Holdings in Masimo Corporation (NASDAQ:MASI)

Massachusetts Financial Services Co. MA raised its position in Masimo Corporation (NASDAQ:MASI - Free Report) by 13.4% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 1,967,838 shares of the medical equipment provider's stock after acquiring an additional 232,671 shares during the period. Massachusetts Financial Services Co. MA owned about 3.64% of Masimo worth $327,842,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC grew its holdings in shares of Masimo by 40.0% during the fourth quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider's stock worth $37,000 after purchasing an additional 64 shares in the last quarter. Xponance Inc. boosted its holdings in shares of Masimo by 1.1% in the 1st quarter. Xponance Inc. now owns 7,101 shares of the medical equipment provider's stock worth $1,183,000 after purchasing an additional 76 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in shares of Masimo by 0.8% in the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 9,815 shares of the medical equipment provider's stock worth $1,622,000 after purchasing an additional 82 shares in the last quarter. Thrivent Financial for Lutherans boosted its holdings in shares of Masimo by 0.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 10,456 shares of the medical equipment provider's stock worth $1,728,000 after purchasing an additional 83 shares in the last quarter. Finally, Orion Portfolio Solutions LLC boosted its holdings in shares of Masimo by 2.1% in the 4th quarter. Orion Portfolio Solutions LLC now owns 4,778 shares of the medical equipment provider's stock worth $790,000 after purchasing an additional 97 shares in the last quarter. Institutional investors own 85.96% of the company's stock.

Masimo Stock Down 1.0%

MASI stock traded down $1.65 during midday trading on Tuesday, hitting $160.04. The company's stock had a trading volume of 461,286 shares, compared to its average volume of 638,630. The company has a quick ratio of 1.62, a current ratio of 2.17 and a debt-to-equity ratio of 0.67. Masimo Corporation has a 52-week low of $101.61 and a 52-week high of $194.88. The firm has a market capitalization of $8.68 billion, a P/E ratio of -17.45 and a beta of 1.19. The firm has a 50-day simple moving average of $161.91 and a 200-day simple moving average of $166.26.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The medical equipment provider reported $1.36 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.12. The firm had revenue of $372.00 million for the quarter, compared to the consensus estimate of $367.79 million. Masimo had a negative net margin of 25.06% and a positive return on equity of 22.56%. The firm's revenue was down 24.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.77 earnings per share. As a group, equities analysts forecast that Masimo Corporation will post 4.1 EPS for the current year.

Insider Buying and Selling

In other Masimo news, COO Bilal Muhsin sold 10,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $163.28, for a total value of $1,632,800.00. Following the transaction, the chief operating officer directly owned 24,172 shares of the company's stock, valued at $3,946,804.16. This represents a 29.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 9.70% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on MASI shares. BTIG Research restated a "buy" rating on shares of Masimo in a report on Monday. Raymond James Financial cut their price target on Masimo from $204.00 to $185.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 7th. Piper Sandler restated an "overweight" rating and issued a $200.00 price target (down previously from $215.00) on shares of Masimo in a research note on Wednesday, May 7th. Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a research note on Thursday, April 10th. Finally, Wall Street Zen downgraded Masimo from a "buy" rating to a "hold" rating in a research note on Friday, May 30th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, Masimo currently has a consensus rating of "Moderate Buy" and an average target price of $191.60.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.